---
title: "Shanmuga Hospital Ltd (544365) — Share Price, Financials & Analysis"
symbol: "544365"
company: "Shanmuga Hospital Ltd"
canonical: "https://tapetide.com/stocks/544365"
isin: "INE0TD301017"
nse_symbol: "SHANMUGAHOSPITALLTD"
bse_code: "544365"
sector: "Healthcare Services"
industry: "Hospitals"
market_cap_cr: 66.65
generated_at: "2026-09-13T19:49:41.737Z"
---

# Shanmuga Hospital Ltd (544365)

Canonical page: https://tapetide.com/stocks/544365

## Company

- **NSE Symbol:** SHANMUGAHOSPITALLTD
- **BSE Code:** 544365
- **ISIN:** INE0TD301017
- **Sector:** Healthcare Services
- **Industry:** Hospitals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2025-02-21
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** shanmugahospital.com

## About

Incorporated in 2020, Shanmuga Hospital Limited is a Multispecialty Hospital situated in Salem, Tamil Nadu.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:44:35.640889Z.

- **Market Cap:** ₹66.65 Cr
- **Classification:** SME
- **P/E (reported):** 15.9
- **Book Value:** ₹31.22
- **Price to Book:** 1.59
- **Dividend Yield:** 0%
- **ROE:** 9.91%
- **ROCE:** 12.84%
- **Debt to Equity:** 0.16
- **Revenue (yearly):** ₹48.1 Cr
- **Net Income:** ₹4.2 Cr
- **EBITDA:** ₹8.9 Cr
- **52-Week High:** ₹56.76
- **52-Week Low:** ₹34
- **RSI (14):** 64.29

## Tapetide Score

- **Score:** 55 / 100
- **Score date:** 2026-09-04
- **Archetype:** Average Quality, Undemanding Price
- **What it means:** The financials sit mid-range rather than strong, and the multiple is not demanding. Nothing here stands out in either direction, so the read comes down to which single pillar you weight most and whether the next results move it off the middle.
- **Pillar profile:** Quality: Average · Valuation: Fair · Momentum: Rising
- **Percentile:** 70.1 (of 4473 scored stocks)
- **Confidence:** 98%
- **Data coverage:** 95%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 70.43 | 9% |
| growth | 35.55 | 9% |
| momentum | 67.4 | 12% |
| ownership | 50 | 24% |
| quality | 50.49 | 22% |
| valuation | 57.94 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has a good return on equity (ROE) track record: 3 Years ROE 16.3%

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 197.39% | 28.5% | 541.15% |
| ebitda margin growth | 10% | 5.16% | -10.14% | -15.81% |
| net income growth | 0% | 0% | -4% | -37.31% |
| revenue growth | 8.18% | 0% | 7% | 3% |
| roce | — | -10.9% | -64.58% | 46.49% |
| roe | — | -6.51% | 17.05% | -89.59% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Jun 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- |
| Sales | 11.48 | 10.85 | 11.87 |
| Expenses | 9.38 | 9.02 | 9.77 |
| Operating Profit | 2.1 | 1.83 | 2.1 |
| OPM % | 18.29 | 16.87 | 17.69 |
| Other Income | 0.1 | 0.15 | 0.04 |
| Interest | 0.09 | 0.09 | 0.08 |
| Depreciation | 0.81 | 0.5 | 0.75 |
| Profit before tax | 1.3 | 1.39 | 1.31 |
| Tax % | 26.92 | 24.46 | 25.19 |
| Net Profit | 0.95 | 1.05 | 0.99 |
| EPS in Rs | 0.7 | 0.77 | 0.73 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Sales | 38.94 | 37.11 | 40.63 | 45.41 | 44.97 |
| Expenses | 29.9 | 29.82 | 32.03 | 37.16 | 36.69 |
| Operating Profit | 9.04 | 7.29 | 8.6 | 8.25 | 8.28 |
| OPM % | 23.22 | 19.64 | 21.17 | 18.17 | 18.41 |
| Other Income | 0.09 | 0.15 | 0.34 | 0.23 | 0.63 |
| Interest | 0.03 | 0.28 | 0.61 | 0.63 | 0.42 |
| Depreciation | 0.13 | 0.58 | 1.3 | 2.16 | 2.82 |
| Profit before tax | 8.97 | 6.58 | 7.03 | 5.69 | 5.67 |
| Tax % | 24.97 | 27.66 | 25.18 | 26.01 | 25.75 |
| Net Profit | 6.72 | 4.76 | 5.25 | 4.21 | 4.21 |
| EPS in Rs | 840 | 595 | 5.36 | 3.09 | 3.09 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Equity Capital | 0.08 | 0.08 | 9.8 | 13.61 | 13.61 |
| Reserves | 6.98 | 11.74 | 7.34 | 26.09 | 28.89 |
| Borrowings | 0 | 7.65 | 9.02 | 7.61 | 6.73 |
| Other Liabilities | 3.59 | 3.58 | 7.76 | 5.47 | 3.82 |
| Total Liabilities | 10.65 | 23.05 | 33.92 | 52.78 | 53.05 |
| Fixed Assets | 2.28 | 9.97 | 15.85 | 22.43 | 37.64 |
| CWIP | 0 | 0 | 4.34 | 0 | 2.44 |
| Investments | 0 | 0.02 | 0.02 | 0.03 | 0.03 |
| Other Assets | 8.37 | 13.06 | 13.71 | 30.32 | 12.94 |
| Total Assets | 10.65 | 23.05 | 33.92 | 52.78 | 53.05 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 1.92 | 2.95 | 9.58 | -12.64 | 12.31 |
| Cash from Investing Activity | -1.67 | -8.31 | -11.59 | -4.48 | -20.33 |
| Cash from Financing Activity | -0.03 | 7.37 | 0.9 | 16.39 | -2.65 |
| Net Cash Flow | 0.21 | 2 | -1.12 | -0.73 | -10.66 |
| Free Cash Flow | 0.24 | -5.32 | -1.93 | -17.04 | -8.16 |
| CFO/OP | 22 | 71 | 129 | -117 | 159 |

### Ratios

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Debtor Days | 44.15 | 57.64 | 62.53 | 63.98 | 55.68 |
| Inventory Days | 19.06 | 36.41 | — | — | — |
| Days Payable | 17.99 | 34.33 | — | — | — |
| Cash Conversion Cycle | 45.22 | 59.71 | 62.53 | 63.98 | 55.68 |
| Working Capital Days | 33.93 | 27.05 | -12.85 | 67.92 | 40.18 |
| ROCE % | — | 51.72 | 33.53 | 17.2 | 12.62 |

## Shareholding Pattern

### Quarterly

| Category | Dec 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Promoters | 71.95% | 72.11% | 72.06% | 72.06% |
| FIIs | 0% | 0.19% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% |
| Public | 25.92% | 24.48% | 24.76% | 24.33% |
| Others | 2.13% | 3.22% | 3.19% | 3.61% |
| No. of Shareholders | 1772 | 1449 | 1156 | 1008 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 12 / 3 / 4

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 44.41 | Buy |
| EMA (10) | 45.95 | Buy |
| SMA (20) | 44.44 | Buy |
| EMA (20) | 44.82 | Buy |
| SMA (50) | 42.2 | Buy |
| EMA (50) | 43.02 | Buy |
| SMA (100) | 40.27 | Buy |
| EMA (100) | 41.99 | Buy |
| SMA (200) | 42.49 | Buy |
| EMA (200) | 41.42 | Buy |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 65.95 | Neutral |
| MACD (12,26,9) | 1.25 | Buy |
| Stochastic (14,3,3) | 91.62 | Sell |
| ADX (14) | 21.63 | Neutral |
| Williams %R (14) | 0 | Sell |
| ATR (14) | 2.13 | High Volatility |
| ROC (12) | 17.02 | Buy |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 70.79 | Sell |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-26 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d1d9e13-f9f3-458b-9889-2444d929b1ad.pdf) |
| 2026-08-25 | [Notice Of The 06Th Annual General Meeting Of Shanmuga Hospital Limited Is Scheduled To Be Held On Friday The 18Th September 2026 At 02.30 P.M. Through Video Conference Or Other Audio Visual Means.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e7c8db1-63f7-4bdc-863f-253838d26d19.pdf) |
| 2026-08-25 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2157acb8-1e02-4536-b9c2-54be6f88debd.pdf) |
| 2026-08-21 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0cb9785-4629-4e10-8209-7dbc66f988a0.pdf) |
| 2026-08-11 | [Board Meeting Outcome for Un-Audited Financial Results And Fixing The Date Of AGM And Employees Stock Option Plan](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71e6c847-cf53-43dc-92d8-ecd258461219.pdf) |
| 2026-08-11 | [Increase In The Authorized Share Capital Of The Company.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d7ba672e-57a7-43ef-958b-bab1555739eb.pdf) |
| 2026-08-11 | [Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be667c7f-d5da-4fa7-9b7c-e914c17cc6a4.pdf) |
| 2026-08-03 | [Board Meeting Intimation for Approving The Unaudited Financial Results For The Quarter Ended June 30 2026 And To Consider And Approve Employee Stock Option Plan.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d6bcb19-dfc1-4d4f-b61a-26cb0c2f3c1e.pdf) |
| 2026-07-13 | [Testing Phase Of "Shanmuga 360" Mobile Application](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b60dbdc-6f04-4bc1-9933-a22d6e583d6b.pdf) |
| 2026-07-07 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e2f884e-2f0d-419f-9faa-9e63421c18f8.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-11 | [Unaudited Financial Results For The Quarter Ended June 302026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61dde8da-5206-4a7c-a61a-2dedc3550cb9.pdf) |
| 2026-05-11 | [Audited Financial Results For The Half Year And Year Ended March 31 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5269cf0c-afa5-4030-b7a0-c860882ba91c.pdf) |
| 2025-11-12 | [Unaudited Financial Results For The Half Year Ended 30Th September 2025 Together With The Limited Review Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9607e657-f8a3-4afe-8428-71f991a982c0.pdf) |
| 2025-05-28 | [Audited Financial Results For The Financial Year Ended 31St March 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b4ec9fa-a5e5-4de2-a6f4-e20cea448072.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9h - M/s J.V. & Co. reappointed as internal auditor for FY 2026-27 on May 11, 2026. | [Announcement under Regulation 30 (LODR)-Change in Management 9h - M/s J.V. & Co. reappointed as internal auditor for FY 2026-27 on May 11, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/fe5220f4-7c55-4a4d-9dec-edfda131165e.pdf) |
| 9h - Board approved audited FY26 results, unmodified audit opinion, and reappointed internal auditor for FY27. | [Board Meeting Outcome for Approval Of Audited Financial Results For The Half Year And Year Ended 31St March 2026. 9h - Board approved audited FY26 results, unmodified audit opinion, and reappointed internal auditor for FY27.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/6bce03fc-b896-4045-bb1c-d20e112e1c5d.pdf) |
| 9h - Approved FY26 audited results, unmodified audit opinion, reappointed internal auditor, and announced voluntary quarterly reporting from FY27. | [Audited Financial Results For The Half Year And Year Ended March 31, 2026. 9h - Approved FY26 audited results, unmodified audit opinion, reappointed internal auditor, and announced voluntary quarterly reporting from FY27.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/5269cf0c-afa5-4030-b7a0-c860882ba91c.pdf) |
| 9 Jan - Commissioned Litho Evo Laser Machine at hospital; ordinary-course purchase, not related party, no material financial impact. | [Intimation Regarding Commissioning And Operationalisation Of Litho Evo Laser Machine 9 Jan - Commissioned Litho Evo Laser Machine at hospital; ordinary-course purchase, not related party, no material financial impact.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e2dcccc0-e3c0-4264-bdc8-359e5c086c4a.pdf) |
| 9 Jan - Certificate pursuant to Regulation 74(5) of SEBI(DP)regulations, 2018 for the period from 01.10.2025 to 31.12.2025 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 9 Jan - Certificate pursuant to Regulation 74(5) of SEBI(DP)regulations, 2018 for the period from 01.10.2025 to 31.12.2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ffe09ff1-0640-4794-b612-7f4eccbcc3df.pdf) |
| 9 Apr - Certificate pursuant to Regulation 74(5) SEBI(DP) Regulations, 2018 for the period from 01.01.2026 to 31.03.2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 9 Apr - Certificate pursuant to Regulation 74(5) SEBI(DP) Regulations, 2018 for the period from 01.01.2026 to 31.03.2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/31ca724c-bc7e-481e-bcc0-1d9250b02e8f.pdf) |
| 8 January 2026 - Certificate under Reg 74(5) for quarter ended Dec 31, 2025: all shares demat; no rematerialisation requests. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 8 January 2026 - Certificate under Reg 74(5) for quarter ended Dec 31, 2025: all shares demat; no rematerialisation requests.](https://nsearchives.nseindia.com/corporate/SANGANIHOSPITALS_08012026131731_SHL_74_5_.pdf) |
| 30 October 2025 - SEBI PIT compliance certificate for quarter ended Sep 30, 2025; SDD maintained; two events captured; no non-compliance. | [Structural Digital Database 30 October 2025 - SEBI PIT compliance certificate for quarter ended Sep 30, 2025; SDD maintained; two events captured; no non-compliance.](https://nsearchives.nseindia.com/corporate/SANGANIHOSPITALS_30102025123004_SHL_SDD.pdf) |
| 30 October 2025 - Company exempt from filing Regulation 27 corporate governance report for quarter ended 30 Sep 2025. | [Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter 30 October 2025 - Company exempt from filing Regulation 27 corporate governance report for quarter ended 30 Sep 2025.](https://nsearchives.nseindia.com/corporate/SANGANIHOSPITALS_30102025121746_SHL_Non_applicability_of_CG.pdf) |
| 30 Apr - Board meets on May 11, 2026 to approve audited FY2026 financial results. | [Board Meeting Intimation for Approving The Audited Financial Results For The Quarter And Year Ended March 31, 2026. 30 Apr - Board meets on May 11, 2026 to approve audited FY2026 financial results.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/33f269a7-ade2-422c-b11e-9c2bfa2cf40d.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2025-11-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1fa4ddb6-706a-430f-a5e6-cca1a7b18589.pdf) |
| 2025-08-11 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4971d055-2ec9-4241-9d2e-fd6805c1fb9d.pdf) |
| 2025-08-07 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae0ee1f1-f734-45df-9148-1188e8cabeea.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Aug 2025 | [Concall - Aug 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ae0ee1f1-f734-45df-9148-1188e8cabeea.pdf) |
| Aug 2025 | [Concall - Aug 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4971d055-2ec9-4241-9d2e-fd6805c1fb9d.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_28248_SANGANI_2024_2025_A_1706159_03092025123252.pdf) |
| from nse | [Financial Year 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_26229_SANGANI_2023_2024_10092024172639.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2d83fdd1-d381-4b26-9ae0-0240004bf910.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:49:41.737Z.